Paper39196121
Kupffer cells dictate hepatic responses to the atherogenic dyslipidemic insult.
Di Nunzio G and 20 others. Nat Cardiovasc Res, 2024. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Kupffer cells dictate hepatic responses to the atherogenic dyslipidemic insult. Papers, record 39196121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39196121
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kupffer Cells | Major topic |
| Liver | Major topic |
| Atherosclerosis | Major topic |
| Disease Models, Animal | Major topic |
| Animals | |
| Male | |
| Hyperlipoproteinemia Type II | |
| Dyslipidemias | |
| Mice, Inbred C57BL | |
| Triglycerides | |
| Apolipoproteins B | |
| Cholesterol | |
| Diet, High-Fat | |
| Apolipoprotein B-100 | |
| Female |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2020-01593 | Vetenskapsrådet (Swedish Research Council) | PubMed | ||
| 2023-02014 | Vetenskapsrådet (Swedish Research Council) | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 39196120 | Linking MASLD to ACVD through Kupffer cells. | https://conductscience.org/library/papers/39196120 |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31420554 | Atherosclerosis. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/31420554 | PubMed |
| 2 | 32052833 | Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. | Eur Heart J | 2020 | https://conductscience.org/library/papers/32052833 | PubMed |
| 3 | 17938300 | Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. | Circulation | 2007 | https://conductscience.org/library/papers/17938300 | PubMed |
| 4 | 6508758 | Quantitative role of parenchymal and non-parenchymal liver cells in the uptake of [14C]sucrose-labelled low-density lipoprotein in vivo. | Biochem J | 1984 | https://conductscience.org/library/papers/6508758 | PubMed |
| 5 | 2845951 | Uptake of LDL in parenchymal and non-parenchymal rabbit liver cells in vivo. LDL uptake is increased in endothelial cells in cholesterol-fed rabbits. | Biochem J | 1988 | https://conductscience.org/library/papers/2845951 | PubMed |
| 6 | 1903931 | Uptake and degradation of human low-density lipoprotein by human liver parenchymal and Kupffer cells in culture. | Biochem J | 1991 | https://conductscience.org/library/papers/1903931 | PubMed |
| 7 | 32227235 | The haemochromatosis gene Hfe and Kupffer cells control LDL cholesterol homeostasis and impact on atherosclerosis development. | Eur Heart J | 2020 | https://conductscience.org/library/papers/32227235 | PubMed |
| 8 | 15566430 | Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process. | Int J Exp Pathol | 2004 | https://conductscience.org/library/papers/15566430 | PubMed |
| 9 | 29875409 | Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. | Nature | 2018 | https://conductscience.org/library/papers/29875409 | PubMed |
| 10 | 28687459 | Mouse models of nonalcoholic steatohepatitis in preclinical drug development. | Drug Discov Today | 2017 | https://conductscience.org/library/papers/28687459 | PubMed |
| 11 | 15731489 | Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. | Arterioscler Thromb Vasc Biol | 2005 | https://conductscience.org/library/papers/15731489 | PubMed |
| 12 | 31630897 | NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin? | Trends Endocrinol Metab | 2019 | https://conductscience.org/library/papers/31630897 | PubMed |
| 13 | 23846497 | Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice. | Arterioscler Thromb Vasc Biol | 2013 | https://conductscience.org/library/papers/23846497 | PubMed |
| 14 | 19805913 | Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19805913 | PubMed |
| 15 | 35679358 | Animal Models of Atherosclerosis-Supportive Notes and Tricks of the Trade. | Circ Res | 2022 | https://conductscience.org/library/papers/35679358 | PubMed |
| 16 | 19307473 | Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. | Circulation | 2009 | https://conductscience.org/library/papers/19307473 | PubMed |
| 17 | 27981604 | Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice. | Hepatology | 2017 | https://conductscience.org/library/papers/27981604 | PubMed |
| 18 | 29880490 | Acute Loss of Apolipoprotein E Triggers an Autoimmune Response That Accelerates Atherosclerosis. | Arterioscler Thromb Vasc Biol | 2018 | https://conductscience.org/library/papers/29880490 | PubMed |
| 19 | 35021063 | Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. | Cell | 2022 | https://conductscience.org/library/papers/35021063 | PubMed |
| 20 | 34321199 | A single-cell type transcriptomics map of human tissues. | Sci Adv | 2021 | https://conductscience.org/library/papers/34321199 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42871858 | Multidimensional regulation of hepatic macrophages in chronic liver disease: from metabolic reprogramming to intercellular and interorgan crosstalk. | Front Immunol | 2026 | https://conductscience.org/library/papers/42871858 | PubMed |
| 42393529 | Mild oxidative stress and dietary epigenetic modulators direct DNA methylation remodeling toward stress-resilience pathways. | BMC Genomics | 2026 | https://conductscience.org/library/papers/42393529 | PubMed |
| 42095527 | A temporal dialogue between the circadian clock and chronic inflammatory diseases. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/42095527 | PubMed |
| 41635536 | Synergistic therapeutic strategies for metabolic dysfunction-associated steatohepatitis and type 2 diabetes mellitus: molecular insights and clinical advances. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41635536 | PubMed |
| 41252283 | Allogeneic haematopoietic cell transplantation promotes atherosclerosis in mice via CD8+ T cells. | Cardiovasc Res | 2025 | https://conductscience.org/library/papers/41252283 | PubMed |
| 40746409 | Metabolic diseases and Kupffer cell's plasticity. | Immunometabolism (Cobham) | 2025 | https://conductscience.org/library/papers/40746409 | PubMed |
| 40725208 | Lipid Accumulation and Insulin Resistance: Bridging Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Kidney Disease. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725208 | PubMed |
| 40331343 | Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement. | Eur Heart J | 2025 | https://conductscience.org/library/papers/40331343 | PubMed |
| 39333539 | Loss of embryonically-derived Kupffer cells during hypercholesterolemia accelerates atherosclerosis development. | Nat Commun | 2024 | https://conductscience.org/library/papers/39333539 | PubMed |
| 39253478 | Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9-Mediated Low-density Lipoprotein Receptor Degradation. | bioRxiv | 2025 | https://conductscience.org/library/papers/39253478 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| APOB | 338 | PubTator's text mining | https://conductscience.org/library/genes/338 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39196121
GET https://conductscience.org/api/papers/v1/39196121/authors?page=2